FDA Approves Lotemax 0.5% Gel Drop Formulation
Lotemax 0.5% (loteprednol etabonate ophthalmic
gel; Bausch + Lomb), a corticosteroid indicated for the
treatment of postoperative inflammation and pain following
ocular surgery, has received FDA approval.
Lotemax is a new topical corticosteroid formulation
in Bausch + Lomb’s line of loteprednol ophthalmic
products...